India to United Kingdom: Ustekinumab Export Trade Route
India has recorded 2 verified shipments of Ustekinumab exported to United Kingdom, representing a combined trade value of $2.8K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $1.4K USD. The leading Indian exporter is NIBA HEALTHCARE, which accounts for 100% of total export value with 1 shipments worth $2.8K USD. On the buying side, ROBERT MCNABB. is the largest importer in United Kingdom with $2.8K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Ustekinumab corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $2.8K USD. The route is dominated by NIBA HEALTHCARE, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's ustekinumab manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $1.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with ustekinumab's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 31 days port-to-port. The route has recorded an annual growth rate of 27.9%, placing it at rank #15 among India's top ustekinumab export destinations globally.
On the import side, key buyers of Indian ustekinumab in United Kingdom include ROBERT MCNABB., XXITHXXS MXXICAXXDEVXXE PXXSICXX. ROBERT MCNABB. is the single largest importer with 1 shipments valued at $2.8K USD.
Route Characteristics
- Average transit31 days
- Peak seasonQ3
- Primary modeSea freight
- Top portBIOCON SEZ
Market Position
- Global rank#15
- Annual growth+27.9%
- Demand growth+25.2%
- Regulatory ease74/100
Top 10 Indian Ustekinumab Exporters to United Kingdom
Showing top 10 of 2 Indian suppliers exporting Ustekinumab to United Kingdom, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NIBA HEALTHCARE Avg $2.8K per shipment | 1 | $2.8K | 99.7% |
| 2 | BIOCON BIOLOGICS INDIA LIMITED Avg $8 per shipment | 1 | $8 | 0.3% |
This table shows the top 10 of 2 Indian companies exporting ustekinumab to United Kingdom, ranked by total trade value. The listed exporters are: NIBA HEALTHCARE, BIOCON BIOLOGICS INDIA LIMITED. NIBA HEALTHCARE is the dominant supplier with 1 shipments worth $2.8K USD, giving it a 100% market share.
Top 10 Ustekinumab Importers in United Kingdom
Showing top 10 of 2 known buyers in United Kingdom receiving Ustekinumab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ustekinumab in United Kingdom include ROBERT MCNABB., XXITHXXS MXXICAXXDEVXXE PXXSICXX. The largest importer is ROBERT MCNABB., accounting for $2.8K USD across 1 shipments — representing 100% of all ustekinumab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ROBERT MCNABB. | 1 | $2.8K | 99.7% |
| 2 | XXITHXXS MXXICAXXDEVXXE PXXSICXX | 1 | $8 | 0.3% |
Top 10 Ustekinumab Formulations Imported by United Kingdom
Showing top 10 of 2 product formulations shipped on the India to United Kingdom Ustekinumab route, ranked by trade value
United Kingdom imports a wide range of ustekinumab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMACEUTICALS PRODUCTS STELARA 90 MG USTEKINUMAB — accounts for $2.8K USD across 1 shipments. A total of 2 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICALS PRODUCTS STELARA 90 MG USTEKINUMAB | 1 | $2.8K | 99.7% |
| 2 | BMAB 1200 USTEKINUMAB | 1 | $8 | 0.3% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
BIOCON SEZ handles the highest volume with 1 shipments. Transit time averages 31 days by sea.
Market Dynamics
India's ustekinumab exports to United Kingdom are driven primarily by a handful of large-scale manufacturers. NIBA HEALTHCARE with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in United Kingdom benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — NIBA HEALTHCARE, BIOCON BIOLOGICS INDIA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $1.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as bmab 1200 ustekinumab, suggesting that buyers in United Kingdom tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ROBERT MCNABB. is the largest importer with 1 shipments worth $2.8K USD — representing 100% of all ustekinumab imports from India on this route.
Route Statistics
- Trade Volume
- $2.8K
- Avg. Shipment
- $1.4K
- Suppliers
- 2
- Buyers
- 2
- Transit (Sea)
- ~31 days
- Annual Growth
- +27.9%
Related Analysis
Reverse Direction
United Kingdom → India — Ustekinumab (Import)Other Ustekinumab Routes
Unlock the Full India to United Kingdom Ustekinumab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 2 shipments on this route.
Frequently Asked Questions — India to United Kingdom Ustekinumab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ustekinumab to United Kingdom?
The leading Indian exporters of Ustekinumab to United Kingdom are NIBA HEALTHCARE, BIOCON BIOLOGICS INDIA LIMITED. NIBA HEALTHCARE holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Ustekinumab exports from India to United Kingdom?
India exports Ustekinumab to United Kingdom worth approximately $2.8K USD across 2 recorded shipments. The average value per shipment is $1.4K USD.
Q Which ports does India use to ship Ustekinumab to United Kingdom?
The most active port of origin is BIOCON SEZ with 1 shipments. Indian exporters primarily use sea freight for this route, with 72% of shipments going by sea and 20% by air.
Q How long does shipping take from India to United Kingdom for Ustekinumab?
The average transit time for Ustekinumab shipments from India to United Kingdom is approximately 31 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United Kingdom Ustekinumab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.9% with demand growth tracking at 25.2%. The route is ranked #15 among India's top Ustekinumab export destinations globally.
Q How many suppliers are active on the India to United Kingdom Ustekinumab route?
There are currently 2 active Indian suppliers exporting Ustekinumab to United Kingdom. The market is moderately concentrated with NIBA HEALTHCARE accounting for 100% of total shipment value.
Q Who are the main importers of Ustekinumab from India in United Kingdom?
The leading importers of Indian Ustekinumab in United Kingdom include ROBERT MCNABB., XXITHXXS MXXICAXXDEVXXE PXXSICXX. ROBERT MCNABB. is the largest buyer with 1 shipments worth $2.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United Kingdom export trade corridor identified from Indian Customs (DGFT) records for Ustekinumab.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 2 importers in United Kingdom matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 2 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists